- Home
- MDGL vs QS Comparison
MDGL vs QS Comparison
Compare MDGL & QS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDGL
- QS
- Stock Information
- Founded
- MDGL 2011
- QS 2010
- Country
- MDGL United States
- QS United States
- Employees
- MDGL N/A
- QS N/A
- Industry
- MDGL Biotechnology: Pharmaceutical Preparations
- QS Auto Parts:O.E.M.
- Sector
- MDGL Health Care
- QS Consumer Discretionary
- Exchange
- MDGL Nasdaq
- QS Nasdaq
- Market Cap
- MDGL 9.6B
- QS 8.8B
- IPO Year
- MDGL N/A
- QS N/A
- Fundamental
- Price
- MDGL $487.04
- QS $17.17
- Analyst Decision
- MDGL Strong Buy
- QS Sell
- Analyst Count
- MDGL 13
- QS 7
- Target Price
- MDGL $514.75
- QS $7.33
- AVG Volume (30 Days)
- MDGL 356.3K
- QS 50.6M
- Earning Date
- MDGL 11-04-2025
- QS 10-22-2025
- Dividend Yield
- MDGL N/A
- QS N/A
- EPS Growth
- MDGL N/A
- QS N/A
- EPS
- MDGL N/A
- QS N/A
- Revenue
- MDGL $740,640,000.00
- QS N/A
- Revenue This Year
- MDGL $395.75
- QS N/A
- Revenue Next Year
- MDGL $65.73
- QS N/A
- P/E Ratio
- MDGL N/A
- QS N/A
- Revenue Growth
- MDGL 864.21
- QS N/A
- 52 Week Low
- MDGL $265.00
- QS $3.40
- 52 Week High
- MDGL $469.95
- QS $19.07
- Technical
- Relative Strength Index (RSI)
- MDGL 69.77
- QS 57.80
- Support Level
- MDGL $399.00
- QS $14.76
- Resistance Level
- MDGL $434.98
- QS $18.56
- Average True Range (ATR)
- MDGL 23.07
- QS 1.50
- MACD
- MDGL 3.22
- QS -0.08
- Stochastic Oscillator
- MDGL 99.85
- QS 77.79
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
About QS QuantumScape Corporation
QuantumScape Corp is engaged in the development of next-generation solid-state lithium-metal batteries for use in electric vehicles and other applications. The company's solid-state lithium-metal battery technology is designed to offer greater energy density, faster charging, and enhanced safety. Its battery cells have none of the host materials used in conventional anodes.